{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T17:13:03Z","timestamp":1723309983742},"reference-count":23,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,9,29]]},"DOI":"10.1536\/ihj.19-625","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T22:04:53Z","timestamp":1599861893000},"page":"905-912","source":"Crossref","is-referenced-by-count":6,"title":["A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation"],"prefix":"10.1536","volume":"61","author":[{"given":"Mihoko","family":"Kawabata","sequence":"first","affiliation":[{"name":"Arrhythmia Advanced Therapy Center, AOI Universal Hospital"},{"name":"Department of Cardiovascular Medicine, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Goya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Maeda","sequence":"additional","affiliation":[{"name":"Arrhythmia Advanced Therapy Center, AOI Universal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiko","family":"Yagishita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hirao","sequence":"additional","affiliation":[{"name":"Arrhythmia Advanced Therapy Center, AOI Universal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med 2015; 128: 1300-5.","DOI":"10.1016\/j.amjmed.2015.05.044"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Okumura Y, Yokoyama K, Matsumoto N, <i>et al<\/i>. Patient Satisfaction with Direct Oral Anticoagulants and Warfarin. Int Heart J 2018; 59: 1266-74.","DOI":"10.1536\/ihj.17-649"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Doherty JU, Gluckman TJ, Hucker WJ, <i>et al<\/i>. 2017 ACC Expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2017; 69: 871-98.","DOI":"10.1016\/j.jacc.2016.11.024"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Steffel J, Verhamme P, Potpara TS, <i>et al<\/i>. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018; 39: 1330-93.","DOI":"10.1093\/eurheartj\/ehy136"},{"key":"5","unstructured":"6. Beckmann A, Spalteholz J, Langer F, <i>et al<\/i>. Perioperative management of direct oral anticoagulants in patients undergoing radical prostatectomy: Results of a prospective assessment. World J Urol 2019 Feb 6 (doi: 10.1007\/s00345-019-02668-z)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Croci DM, Kamenova M, Guzman R, Mariani L, Soleman J. Novel Oral Anticoagulants in Patients Undergoing Cranial Surgery. World Neurosurg 2017; 105: 841-8.","DOI":"10.1016\/j.wneu.2017.06.105"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. Croci DM, Dalolio M, Guzman R, <i>et al<\/i>. Direct oral anticoagulants in patients undergoing spine surgery. World Neurosurg 2019; 125: e1034-41.","DOI":"10.1016\/j.wneu.2019.01.236"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Douketis JD, Spyropoulos AC, Duncan J, <i>et al<\/i>. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 2019; 179: 1469-78.","DOI":"10.1001\/jamainternmed.2019.2431"},{"key":"9","doi-asserted-by":"publisher","unstructured":"10. Healey JS, Eikelboom J, Douketis J, <i>et al<\/i>. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation 2012; 126: 343-8.","DOI":"10.1161\/CIRCULATIONAHA.111.090464"},{"key":"10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","volume":"12","year":"2010","unstructured":"11. Camm AJ, Kirchhof P, Lip GY, <i>et al<\/i>. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-420.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"11","doi-asserted-by":"publisher","unstructured":"12. Calkins H, Hindricks G, Cappato R, <i>et al<\/i>. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2018; 20: e1-e160.","DOI":"10.1093\/europace\/eux274"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-4.","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Rose DK, Bar B. Direct oral anticoagulant agents: pharmacologic profile, indications, coagulation monitoring, and reversal agents. J Stroke Cerebrovasc Dis 2018; 27: 2049-58.","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Blann AD, Lip GYH. Laboratory monitoring of the non-vitamin K oral anticoagulants. J Am Coll Cardiol 2014; 64: 1140-2.","DOI":"10.1016\/j.jacc.2014.07.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Samuelson BT, Cuker A, Siegal DM, Crowther M, Garcia DA. Laboratory assessment of the anticoagulant activity of direct oral anticoagulants (DOACs): a systematic review. Chest 2016; 151: 127-38.","DOI":"10.1016\/j.chest.2016.08.1462"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Kawabata M, Goya M, Sasaki T, <i>et al<\/i>. Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy - warfarin vs. direct oral anticoagulants. Circ J 2017; 81: 645-51.","DOI":"10.1253\/circj.CJ-16-1089"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Lerman BJ, Popat RA, Assimes TL, Heidenreich PA, Wren SM. Association between heart failure and postoperative mortality among patients undergoing ambulatory noncardiac surgery. JAMA Surg 2019; 154: 907-14.","DOI":"10.1001\/jamasurg.2019.2110"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Fowler AJ, Ahmad T, Phull MK, <i>et al<\/i>. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg 2015; 102: 1314-24.","DOI":"10.1002\/bjs.9861"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Mashour GA, Shanks AM, Kheterpal S. Perioperative stroke and associated mortality after noncardiac, nonneurologic surgery. Anesthesiology 2011; 114: 1289-96.","DOI":"10.1097\/ALN.0b013e318216e7f4"},{"key":"20","first-page":"1723","volume":"110","year":"2007","unstructured":"21. Varki A. Trousseau&apos;s syndrome: Multiple definitions and multiple mechanisms. Blood 2007; 110: 1723-9.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Tripodi A. The laboratory and the direct oral anticoagulants. Blood 2013; 121: 4032-5.","DOI":"10.1182\/blood-2012-12-453076"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Crowther M, Crowther MA. Antidotes for novel oral anticoagulants: current status and future potential. Arterioscler Thromb Vasc Biol 2015; 35: 1736-45.","DOI":"10.1161\/ATVBAHA.114.303402"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. Favaloro EJ, Bonar R, Butler J, Marsden K. Laboratory testing for the new oral anticoagulants: a review of current practice. Pathology 2013; 45: 435-7.","DOI":"10.1097\/PAT.0b013e328360f02d"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_19-625\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:20Z","timestamp":1601697380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_19-625\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-625","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}